Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities
The EMPA-KIDNEY, Collaborative G, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R
Several studies have been conducted in the context of liver fibrosis, suggesting that MSH reduces markers of fibrosis in the carbon tetrachloride (CCl4) and in the thioacetamide-induced mouse models of liver fibrosis (190, 191)
For current pricing, see our [semaglutide cost guide](/guides/semaglutide-cost-price-guide-2026).* --- ## References - [Ozempic (semaglutide) Prescribing Information]( *Novo Nordisk / FDA*, 2024
However, while these results are compelling, the authors emphasize that this is a single-subject observation and underscore the need for large-scale randomized clinical trials to validate semaglutide and similar GLP-1 RAs as primary AUD treatments
It summarizes laboratory and animal research trends with citations for readers to evaluate
